HLA-DRB4 gene encoded HLA-DR53 specificity segregating with the HLA- DR7, -DQ9 haplotype: Unusual association

Human Immunology

Volumn 59, Issue 2, 1998, Pages 115-118

  Lardy, N M ^b   Van Der Horst, A R ^c   Van De Weerd, M J ^c   De Waal, L P ^c   Bontrop, R E ^a  

^a Biochemical Primate Research Centre   (Netherlands)

^b CENTRAL LABORATORY   (Netherlands)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR7 ANTIGEN;

ALLOTYPE; ANTIGENIC VARIATION; ARTICLE; CASE REPORT; EPITOPE MAPPING; GENE MAPPING; GENETIC LINKAGE; HAPLOTYPE; HLA TYPING; HUMAN; LEUKEMIA; PEDIGREE ANALYSIS; PRIORITY JOURNAL;

FEMALE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HLA-DR7 ANTIGEN; HUMANS; MALE; PEDIGREE; POLYMERASE CHAIN REACTION;

EID: 0032005843     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(97)00264-4     Document Type: Article

References (12)

1. Mukai R, Suzuki M, Yabe T, Hamaguchi H, Maeda H. Identification of the MT3 molecule from HLA-DR4, 7, w9 homozygous cell lines. J Immunol. 33:1984;321.
2. Knowles RW, Flomenberg N, Horibe K, Winchester R, Radka SF, Dupont B. Complexity of the supertypic HLA-DRw53 specificity Two distinct epitopes differentially expressed on one or all of the DR β-chains depending on the HLA-DR allotype . J Immunol. 137:1986;2618.
3. 2 subunits in DR4, 7, and w9 haplotypes and the DRw53 (MT3) specificity. J Immunol. 137:1986;934.
4. Marsh SGE, Du Toit ED Bunce M, Moses JH, Martel R, Morris P, De Waal L, Johnson A, Fotino M. Antigen Society no. 208/209 HLA-DR52, -DR53 . Tsuji K, Aizawa M, Sasazuki T. HLA 1991, vol I Proceedings of the Eleventh International Histocompatibility Workshop and Conference . 1992;376 Oxford University Press, Oxford.
5. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Fauchet R, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMTh Strominger JL, Svegaard A, Terasaki PI. Nomenclature for the factors of the HLA system, 1996. Tissue Antigens. 9:1997;297.
6. Sutton VR, Knowles RW. Mapping of a restriction fragment length polymorphism associated with defective DRβ4 chain expression to the HLA-DRB1 gene. Hum Immunol. 22:1988;123.
7. Sutton VR, Kienzle BK, Knowles RW. An altered splice site is found in the DRB4 gene that is not expressed in HLA- DR7,Dw11 individuals. Immunogenetics. 29:1989;317.
8. Sutton VR, Knowles RW. An abberant DRB4 null gene transcript is found that could encode a novel HLA-DRβ chain. Immunogenetics. 31:1990;112.
9. Robbins F, Hurley CK, Tang T, Yao H, Lin YS, Wade J, Goeken N, Hartzman RJ. Diversity associated with the second expressed HLA-DRB locus in the human population. Immunogenetics. 46:1997;104.
10. van Rood JJ, van Leeuwen A, Ploem JS. Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature. 262:1976;795.
11. Lardy NM, van der Horst AR, van den Berg-Loonen EM, Bontrop RE, de Waal LP. Fine Specificity of the Alloantiserum MSD-51 Epitope Mapping of HLA-DRw53 Determinants . Hum immunol. 32:1991;65.
12. Gregersen PK, Kao H, Nunez-Roldan A, Hurley CK, Karr RW, Silver J. Recombination sites in the HLA class II region are haplotype-dependent. J Immunol. 141:1988;1365.